Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Darbepoetin Alfa |
Trade Name | Aranesp |
Synonyms | NESP|Nespo|Novel Erythropoiesis Stimulating Protein |
Drug Descriptions |
Aranesp (darbepoetin alfa) is a recombinant analog of erythropoietin, which upon binding to the erythropoietin receptor, induces differentiation of erythroid progenitor cells into mature red blood cells (PMID: 16333460). Aranesp (darbepoetin alfa) is approved for the treatment of anemia in patients with cancer and chronic kidney disease (FDA.gov). |
DrugClasses | |
CAS Registry Number | 209810-58-2 |
NCIT ID | C1878 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Canakinumab + Darbepoetin Alfa | Canakinumab Darbepoetin Alfa | 0 | 1 |
Darbepoetin Alfa | Darbepoetin Alfa | 0 | 0 |